XTNT stock results show that Xtant Medical Hldgs missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
Articles
RXRX Stock Earnings: Recursion Pharmaceuticals Meets EPS, Beats Revenue for Q2 2024
RXRX stock results show that Recursion Pharmaceuticals met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
EWTX Stock Earnings: Edgewise Therapeutics Beats EPS for Q2 2024
EWTX stock results show that Edgewise Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
Palantir Technical Analysis: Bulls Go on the Offensive!
In the wake of Palantir Technologies' excellent quarterly data release, Palantir technical analysis shows that the buyers have the upper hand. More
Hot Stocks: 7 Hidden Gems Will THRIVE in a Low Interest Rate Environment
Under-the-radar winners across sectors and industries are set to thrive as anticipated lower interest rate is anticipated. More
Why AMD Stock Is Still a Buy Despite the Recent Selloff
Let's dive into where AMD stock could be headed from here, as market volatility picks up and chip stocks see bifurcation build. More
DUOL Stock Soars on Q2 Earnings: What is Duolingo Doing Right?
Duolingo is a company that appears to be taking off according to its recent earnings release. Here's why DUOL stock is soaring today. More
